# Enzyme Capital

Enzyme Capital is a Private Equity based in Beijing, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Beijing, China
- **Region:** Asia
- **Address:** Beijing, China
- **Founded:** 2017
- **Assets under management:** Undisclosed
- **Website:** enzymecapital.com
- **LinkedIn:** https://www.linkedin.com/company/enzymefinance

## Regulatory record

- **Reports private funds:** No

## About

Enzyme is the global infrastructure for tokenized finance. It empowers businesses and institutions with a comprehensive suite of products to create and manage next-generation financial products and strategies. Originally designed exclusively for asset managers, it evolved after eight years into infrastructure empowering businesses and institutions to scale through tokenization.

## Sectors

- Tokenized finance and decentralized finance

## People

- Mona El Isa — Founder

## Questions

### Does Enzyme Capital co-invest alongside other venture firms?

Enzyme Capital's approach to co-investing is not publicly documented. As an early-stage firm operating in Beijing's venture ecosystem, participation in syndicated seed rounds alongside other specialist funds is common practice, but no specific co-investment partners or deal syndicates have been confirmed through public record or the firm's own disclosures.

## Related profiles

- [Envolve Group](https://altss.com/profile/envolve-group)
- [Epicenter Logistics Innovation Accelerator](https://altss.com/profile/epicenter-logistics-innovation-accelerator)

---

Updated: 2026-08-11T15:06:42.396Z

Canonical page: https://altss.com/profile/enzyme-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology